| F |
|
Factor V Inhibitor Acquired after Exposure to High-Purity Topical Bovine Thrombin during Orthopedic Surgery
|
| Harris SB, Benson E, Duncan A |
| |
|
Factor V Kuwait: a New Point Mutation in the Coagulation Factor V Gene
|
| Jadaon MM, Dashti AA |
| |
|
Factor V Leiden and Aprotinin in Cardiopulmonary Bypass
|
| Linden MD, Schneider M, Erber WN |
| |
|
Factor V Leiden and Prothrombin G20210A Mutations in Children with Cerebral Palsy
|
| Ulutin T, Tezol A, Yüksel A, Buyearu N |
| |
|
Factor V Leiden and R2 Mutations, Prothrombin G20210A Mutation and Osteonecrosis
|
| Zalavras C, Malizos K, Dova L, Zibis A, Dokou E, Dailiana Z, Kolaitis N, Vartholomatos G |
| |
|
Factor V Leiden as a Modifier of the Severe Hemophilia Phenotype in Murine Models
|
| Schlachterman A, Liu J, Liu Y-L, Camire RM, Arruda VR |
| |
|
Factor V Leiden Mutation and Pregnancy Associated Venous Thromboembolism: A Meta-Analysis
|
| Biron-Andreani C, Schved JF, Daures JP |
| |
|
Factor V Leiden: An Important Risk Factor for Venous and Arterial Thrombosis in Brazilian Patients
|
| Sabino AP, Ribeiro DD, Guimarães DAM, Soares AL, Carvalho MG, Fernandes AP, Dusse LMS, Vieira LM, Cardoso JE |
| |
|
Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency
|
| Shinozawa K, Inaba H, Amano K, Suzuki T, Takahashi H, Iijima K, Tanaka A, Arai M, Fukutake K |
| |
|
Factor Va Membrane Binding Affinity and Prothrombinase Activity are Enhanced by Incorporation of Phosphatidylethanolamine into Phosphatidylserine Containing Membranes
|
| Liang X, Quinn-Allen MA, Kane WH |
| |
|
Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo
|
| Kanse SM, Linn T, Sürücü O, Matz R, Henning S, Dietz C, Weimer T, Preissner KT, Celik I |
| |
|
Factor VII Arg277His Mutation Induced Discrepancy of Factor VII Activity Levels Using Tissue Factor from Different Sources
|
| Tarumi T, Kanazawa K, Ieko M, Mizukami M, Yoshida M, Naito S, Nakabayashi T, Notoya A, Koike T |
| |
|
Factor VIIa Binding and Internalization in Hepatocytes
|
| Hjortoe GM, Sorensen BB, Petersen LC, Rao LVM |
| |
|
Factor VIII / LRP Interactions
|
|
| |
|
Factor VIII Activity and Antigen, VWF and ABO-Genotype Are Not Associated with Coronary Heart Disease
|
| Bach J, Preiss A, Haubelt H, Winkelmann BW, Maerz W, Boehm B, Hellstern P |
| |
|
Factor VIII and von Willebrand Factor Changes after Desmopressin and During Pregnancy in Type 2M von Willebrand Disease Vicenza: A Prospective Study Comparing Patients with Single (R1205H) and Double (R1205H-M740I) Defect
|
| Castaman G, Federici AB, Bernardi M, Moroni B, Bertoncello K, Rodeghiero F |
| |
|
Factor VIII Coagulant Activity and Antigen Levels Increase the Risk of Venous Thrombosis; Results of the MEGA Study
|
| Doggen CJM, Bertina RM, Rosendaal FR |
| |
|
Factor VIII Expression Induces ER Stress Apoptosis In Cultured Cells and in Mice
|
| Malhotra J, Maio H, Pipe SW, Kaufman RJ |
| |
|
Factor VIII Inhibitor in a Patient with Mild Haemophilia A
|
| Santoro R, Iannaccaro P, Muleo G |
| |
|
Factor VIII Inhibitors in Hemophilia A during Immune Tolerance Induction
|
| van Helden PMW, Gouw SC, Mauser-Bunschoten EP, van den Berg HM, Voorberg J |
| |
|
Factor VIII Inhibitors in Mild Haemophilia A. Incidence in Patients with Arg2150His Mutation in South of Spain
|
| Perez R, Nuñez R |
| |
|
Factor VIII Levels and Blood Coagulation in Patients on Long-Term Oral Anticoagulation (OA)
|
| Brzezinska-Kolarz B, Undas A, Padjas A, Iwaniec T, Musial J |
| |
|
Factor VIII Mimetic Antibody: (1) Establishment and Characterization of Anti-factor IX/Anti-factor X Bispecific Antibodies
|
| Saito H, Kojima T, Miyazaki T, Soeda T, Kitazawa T, Suzuki T, Yoshihashi K, Adachi H, Nezu J, Shima M, Yoshioka A, Hattori K |
| |
|
Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A
|
| Shima M, Matsumoto T, Sakurai Y, Takeyama M, Tanaka I, Saito H, Hattori K, Yoshioka A |
| |
|
Factor VIII Mutation Type in Severe and Moderate Haemophilia A, and Inhibitor Development in a Congenital Coagulopathies Unit
|
| Haya S, Casaña P, Cabrera N, Cid AR, Cortina V, Querol F, Aznar JA |
| |
|
Factor VIII Residues 97–105 and 1954–1961 of the A1 and A3 Domains Represent an Inter-Subunit Interface
|
| Ansong CA, Miles SM, Fay PJ |
| |
|
Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism
|
| Martinelli N, Girelli D, Lunghi B, Olivieri O, Scanavini D, Manzato F, Lotto V, Tenuti I, Bozzini C, Friso S, Pizzolo F, Corrocher R, Bernardi F |
| |
|
Factor VIIIa Regulates Substrate Delivery to the Intrinsic Factor X-Activating Complex
|
| Panteleev MA, Ananyeva NM, Greco NJ, Ataullakhanov FI, Saenko EL |
| |
|
Factor X Deficiency: Clinical Manifestation of 102 Subjects with Mutations in Factor 10 Gene
|
| Herrmann FH, Auerswald G, Ruiz-Saez A, Navarette M, Pollmann H, Lopaciuk S, Batorova A, Wulff K |
| |
|
Factor X Gene Mutations Affecting the Gla Domain of the Protein
|
| Akhavan S, Chafa O, Nsoure Obame F, Serve E, Torchet M-F, Reghis A, Fischer A-M, Tapon-Bretaudière J |
| |
|
Factor Xa-Directed Inhibition in Plasma from Patients Undergoing Coumadin Treatment: Observations Relevant to Bridging Therapy
|
| Gould WR, Shafer SS, Leadley Jr RJ |
| |
|
Factor XI Deficient Mice Have Reduced Platelet Accumulation and Fibrin Deposition after Laser Injury
|
| Baird TR, Gailani D, Furie, Br1,2 , Furie Ba |
| |
|
Factor XII (fXII) Is Activated by Unfolded Proteins on the Surface of Negatively Charged Substances, Rather than by These Surfaces Themselves
|
| Bouma B, Maas C, Schiks B, de Groot PhG, Gebbink MFBG |
| |
|
Factor XIII Levels and Factor XIII a Subunit Val34Leu Polymorphism in Patients with Coronary Sclerosis and Myocardial Infarction
|
| Katona É, Bereczky Z, Balogh E, Czuriga I, Kárpáti L, Édes I, Muszbek L |
| |
|
Factor XIII Val34Leu Polymorphism in Croatian Population
|
| Broni[cacute] A, Feren[ccaron]ak G, Zadro R, Stavljeni[cacute] Rukavina A |
| |
|
Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction
|
| Marín F, González-Conejero R, Lee KW, Corral J, Roldán V, López F, Sogorb F, Caturla J, Lip GYH, Vicente V |
| |
|
Factors Therapy in Surgical Patients without Hemophilia
|
| Roitman E |
| |
|
Failure of Anticoagulation in Kawasaki Disease
|
| Girisch M, Wiegand G, Rauch R |
| |
|
Failure of the Outpatient Bleeding Risk Index to Predict Major Bleeding in Older Patients Receiving Coumarin for Atrial Fibrillation
|
| Ceresetto JM, Duboscq C, Rabinovich O, Stemmelin G, Shanley C, Doti C, Vicente MA, Gonzalez Vucovik M, Bullorsky E |
| |
|
False Positives Account For Low Conversion Frequency In Chimeraplasty For Von Willebrand Disease
|
| De Meyer SF, Pareyn I, Baert J, Deckmyn H, Vanhoorelbeke K |
| |
|
Family with Inherited f.X Deficiency. Case Report
|
| Plahuta TG, Larina LE, Svirin PV, Shiller EE, Soskov GI |
| |
|
Fatal Hemorrhagic Disorder and Vascular Intimal Carcinomatosis in Annexin II Expressing Transitional Cell Carcinoma
|
| Seiji M, Mitsugu H, Hiroshi K, Tsukasa O, Teruko S, Jun M, Keiya O, Ken S, Yoichi S |
| |
|
Fatal Pulmonary Embolism and Cancer. A Study of 21 500 Post-Mortems over 35 years
|
| Cohen AT, Weston GJ, Tasker AJ, Fellows GA, Wilmott R |
| |
|
Fatal Vascular Outcomes Following Major Orthopedic Surgery
|
| Dahl OE, Caprini JA, Colwell Jr. CW, Frostick SP, Haas S, Hull RD, Laporte S, Stein PD |
| |
|
Favorable Outcome in the Pregnancy behind Treatment with Heparin in Women with Mutation of Methylenetetrahydrofolate Reductase (MTHFR) Gene and Fetal Loss Previous
|
| Fisac Herrero R, Santamaria R, Olivier C, Hernandez J, Queizan J, Fisac Martin M, Martinez M, Calmuntia M |
| |
|
Favourable Pregnancy Outcome in Women with a History of Venous Thromboembolism and Prophylactic Low Molecular Weight Heparin (LMWH)
|
| Alguel G, Vormittag R, Kyrle PA, Quehenberger P, Mannhalter C, Pabinger I |
| |
|
FcgRIIa Platelet Polymorphism in Asian Indians: Its Association with Development of Heparin Induced Thrombocytopenia
|
| Kannan M, Ahmad F, Ahmad S, Kale S, Fareed J, Saxena R |
| |
|
FEIBA – Mode of Action
|
| TurecekVáradi PLK, Gritsch H |
| |
|
FEIBA Use for Acquired Hemophilia
|
| Boggio L |
| |
|
Fetal Loss in Hereditary Antithrombin, Protein C and Protein S Deficiencies
|
| Korteweg FJ, Brouwer JLP, Folkeringa N, Veeger NJGM, Erwich JJHM, Holm JP, van der Meer J |
| |
|
Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells
|
| Fons P, Hérault J-P, Géronimi F, Guéguen G, Delesque N, Challier C, Laplace M-C, Tuyaret J, Schaeffer P, Savi P, Bono F, Herbert J-M |
| |
|
Fibrin and b-chain Peptide (441–461) for Tissue Engineering Improves Tolerability and Efficiency of Non-viral Gene Vector Formulations
|
| Stemberger A, Kullmer M, Koch C, Schillinger U, Plank C |
| |
|
Fibrin and Other Ligands Regulate the Kinetics of Non-proteolytic Active Site Formation in Plasminogen
|
|
| |
|
Fibrin Clot Deformability: Influence of Fibrinogen Concentration
|
| Savushkin AV |
| |
|
Fibrin D-Dimer, by Three Different Assays, is an Independent Predictor of Future Stroke in Patients With Atrial Fibrillation
|
| Tait RC, Rumley A, McMahon AD, Murdoch DL, O’Neill KF, Wallace IW, Lowe GDO |
| |
|
Fibrin Monomers in the Diagnosis of Deep Vein Thrombosis
|
| Schutgens REG, Haas FJLM, Biesma DH |
| |
|
Fibrin-Monomer Prepared Using Thrombin-Like Enzyme from Snake Venom Agkistrodon Halys as Stimulator of Plasminogen Activation By t-PA
|
| Moukhametova LI, Aisina RB, Boulyguine OY, Varfolomeyev SD |
| |
|
Fibrinogen and Fibrin Structure and Functions
|
| Mosesson MW |
| |
|
Fibrinogen May Predict Death from Cancer in Men with Lower Extremity Arterial Disease
|
| MacCallum PK, Cooper JA, Meade TW |
| |
|
Fibrinogen Paris IX: A Case of Symptomatic Hypofibrinogenaemia Associated With Bbeta Y236C and Bbeta IVS7 -1G > C Mutations
|
| Horellou MH, Chevreaud C, Mathieux V, Conard J, de Mazancourt P |
| |
|
Fibrinogen Storage Disease with Hypofibrinogenaemia
|
| Santoro R, Iannaccaro P, Muleo G |
| |
|
Fibrinogen Variants of the Gamma Chain Coiled-Coil Portion Detected by Reverse Phase HPLC in Patients with Venous Thrombosis
|
| Hanss MML, Vergnes C, Berruyer M, Ffrench PO, Dargaud Y, Rousson R, De Mazancourt P |
| |
|
Fibrinogen, Plasminogen Activator Inhibitor-1, and Interleukin-6 in Peripheral Arterial Disease of Type 2 Diabetes Patients
|
| Hutajulu SH, Kurnianda J, Asdie RH, Wiyono P, Asdie AH |
| |
|
Fibrinogen-Aa Thr 312 Ala and Factor XIII Val 34 Leu Polymorphisms in Idiopathic Venous Thromboembolism
|
| Le Gal G, Delahousse B, Regina S, Malaviolle V, Lacut K, Oger E, Mottier D, Gruel Y |
| |
|
Fibrinolytic Activity in the Patients with Buerger's Disease and PAOD
|
| Terlecki P, Przywara S, Zubilewicz T, Feldo M, Ilzecki M, Kesik J, Wronski J |
| |
|
Fibrinolytic Activity Is Enhanced after Major Orthopedic Surgery
|
| O'Donnell M, Stafford A, Johnston M, Fredenburgh JC, Weitz JI |
| |
|
Fibrinolytic Gene Polymorphism and Ischemic Stroke
|
| Jood K, Ladenvall P, Tjärnlund Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C |
| |
|
Fibrinolytic Peritoneal Response to Laparoscopic Surgery
|
| Duboscq C, Amarillo H, Roca J, Ceresetto JM, Shanley C, Stemmelin G, Rabinovich O, Doti C, Porto E, Bullorsy EO |
| |
|
Fibronectin-Binding Protein (FnBP) Mediates Staphylococcus Aureus-Induced Platelet Aggregation
|
| Fitzgerald JR, Loughman A, Brennan M, Knobel M, Higgins J, Speziale P, Cox D, Foster TJ |
| |
|
Fine Epitope Mapping of Human Monoclonal Antibodies Directed Against the B Domain of Factor VIII
|
| Lavigne-Lissalde G, Lacroix-Desmazes S, Schved JF, Granier C, Kaveri SV, Villard S |
| |
|
Fine Mapping of the Prothrombin Binding Site in the Apple 1 Domain of Factor XI
|
| Baglia FA, Gailani D, Papagrigoriou V, Emsley J, Walsh pN |
| |
|
First Case of Compound Heterozygous Mutations in the Kininogen Gene Causing Severe High-Molecular-Weight Kininogen Deficiency
|
| Geisen C, Grünewald M, Renne T, Watzka M, Muller-Esterl W, Seifried E, Oldenburg J |
| |
|
First Line Therapy with FEIBA® for the Intracranial Hemorrhages in Haemophilia Patients with Inhibitors
|
| Musso R, Cultrera D, Musso M, Cipolla A, Giustolisi R |
| |
|
Fish Skins as a Source of Heparin-Like GAGs
|
| Coyne E, Jeske WP, McDonald MK, Maddineni J, Mendes A, Dietrich CP, Walenga JM |
| |
|
FIX Activation on the Surface of Activate Platelets by rFVIIa in the Absence of Tissue Factor
|
| Gabriel DA, Monroe DM, Roberts HR |
| |
|
FLEXTRA: Early vs Delayed Initiation of Postoperative Fondaparinux Prophylaxis after Joint Replacement: A Clinical Outcome Study
|
| Davidson BL, Turpie AGG, Kwong LM, Colwell CW, Jr |
| |
|
Flow Cytometric Analysis of Platelet Activation Via Recombinant Factor VIIa
|
| Nolen JDL, Webber B, Duncan A |
| |
|
Fluorescence-Based Study of Nonsense Mutation Suppression in Coagulation Factor VII Deficiency
|
| Pinotti M, Rizzotto L, Pinton P, Ferraresi P, Chuansumrit A, Charoenkwan P, Canella A, Marchetti G, Rizzuto R, Mariani G, Bernardi F |
| |
|
Following Cardiac Surgery Patients Who Develop Biphasic Waveforms as Seen on the MDA-180 Automated Coagulation Analyser Have Increased Thrombin Potential in-vitro. This Is Partly due to Tissue Factor Present in the CRP-VLDL Complex
|
| Davidson SJ, Al-Mazedi M, Burman JF |
| |
|
Follow-Up of Patients with Acute Venous Thromboembolism Treated with Ximelagatran for Prophylaxis of Recurrent Events
|
| Harenberg J, Jörg I, Müller G, Öttler W, Diehm C, Stein U, Schellong S |
| |
|
Fondaparinux Combined with Intermittent Pneumatic Compression (IPC) Versus IPC Alone in the Prevention of VTE after Major Abdominal Surgery: Results of the APOLLO Study
|
| Turpie AG, Bauer K, Caprini J, Comp P, Gent M, Muntz J |
| |
|
Fondaparinux Use in Heparin-Induced Thrombocytopenia
|
| Boggio L, Soff G, Zakarija A, Green D |
| |
|
Food Intake Enhances Platelet Reactivity to Thromboxane in Type 2 Diabetic Patients
|
| Li N, Yngen M, Daleskog M, Johansson M-C, Wallén NH, Östenson C-G, Hjemdahl P |
| |
|
Four Direct Thrombin Inhibitors (DTIs) Variably Increase the Prothrombin Time: A Consequence of Differing Therapeutic Molar Concentrations?
|
| Warkentin TE, Greinacher A, Craven S, Dewar L, Sheppard JI, Ofosu FA |
| |
|
Four Novel Missense Mutations in Factor IX Gene Were Identified as Causes of Hemophilia B
|
| Shu A, Suzuki T, Shinozawa K, Inaba H, Tsujikawa A, Kokaji T, Arai M, Fukutake K |
| |
|
Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood
|
| Schulz C, Schafer A, Stolla M, Lorenz M, Bauersachs J, Gawaz M, Massberg S |
| |
|
Frequency of Anticardiolipin (aCL) Antibodies in Patients with Lupus Anticoagulant (LA) Detected by Different Methods: An Analysis of 4265 Cases
|
| Franco RF, Matos MF, Leser PG, Villela MSH, Figueiredo MS |
| |
|
Functional Analyses of the Reconstituted AlphaIIbbeta3 and AlphaVbeta3 Minireceptors
|
| Bledzka-Krupska K, Michalec L, Szymanski J, Kish M, Plow EF, Cierniewski CS |
| |
|
Functional Analysis o Two Recombinant Missense Mutant Factor XI, F221S ad C212R
|
| Kuroda K, Morishita E, Hirano K, Yamazaki K, Sekino T, Yamazaki M, Asakura H, Nakao S, Ohtake S |
| |
|
Functional Analysis of A -13 G/A Dimorphism at the Major Transcription Initiation Site of the Protein Z Gene
|
| Winship PR, Haridas S, Wragg MM, Prasad S, Hall AJ |
| |
|
Functional Analysis of Obligate Heterozygous Defects in Platelet Glycoprotein (GP) Ib-V-IX in Velo-Cardio-Facial Syndrome (VCFS) Patients
|
| Liang HPH, Morel-Kopp MC, Curtin J, Wilson M, Hewson J, Ward CM |
| |
|
Functional Analysis of the Factor Ix Egf-Like Domain Mutation Ile66thr Associated with Mild Hemophilia B
|
| Knobe KE, Persson KEM, Sjörin E, Villoutreix BO, Ljung RCR |
| |
|
Functional Characterization of the FXIII Cross Linking Sites in the Fibrinogen g-Chain
|
| Standeven KF, Carter AM, Masova L, Lord ST, Weisel JW, Grant PJ, Ariëns RAS |
| |
|
Functional Decrease in Thrombin Activatable fibrinolytic Inhibitor by Anticoagulant Drugs: A Possible Explanation for the Observed Profibrinolytic Actions
|
| Florian-Kujawski M, Hoppensteadt D, Maddineni J, Wilmer M, Ziegler H, Fareed J |
| |
|
Functional Differences in the Response of Platelets to Collagen That Are Linked to Glycoprotein VI Genotype Are Also Associated with Differences in Platelet Gene Expression Profiles
|
| Carr P, Macaulay IC, Dudbridge F, Tom B, Langford CF, Smethurst PA, Watkins NA, Ouwehand WH |
| |
|
Functional Duplication of Ligand-Binding Domains within Low-Density Lipoprotein Receptor-Related Protein for Interaction with Alpha2-Macroglobulin, Factor IXa and Factor VIII
|
| Meijer AB, Rohlena J, van der Zwaan C, Boertjes RC, Lenting PJ, Mertens K |
| |
|
Functional Evidence for Three I-domain Activation States for Platelet a2b1 Integrin
|
| Siljander P, Schoolmeester A, Smerling C, Van de Walle G, Hamaia S, Deckmyn H, Farndale RW |
| |
|
Functional Role of Human P-Selectin (CD62P) Polymorphisms in Mediating Cell-Cell Interactions
|
| Barek L, Touka MA, Cerutti C, Barbaux S, Cambien F, McGregor JL |
| |
|
Further Characterization of the Mutation in Blade 2 of the aIIb b-Propeller That Causes Glanzmann Thrombasthenia in Palestinian Arabs
|
| Rosenberg N, Hauschner H, Landau M, Seligsohn U |
| |
|
Further Evidence for Ping-Pong-Like Mechanism for Prothrombinase from Analysis of the Time Courses of Prothrombin, Meizothrombin, Prethrombin-2, and Thrombin During Prothrombin Activation
|
| Kim PY, Nesheim ME |
| |
|
Fusion of the N-terminal Acidic Domain of Heparin Cofactor II to a1-PI M358R Increases the Rate of Thrombin Inhibition
|
| Sutherland JS, Bhakta V, Filion ML, Sheffield WP |
| |
|
FV Leiden Mitigates Bleeding Tendency in Recessive Type 1 von Willebrand Disease
|
| Casonato A, Sartorello F, Pontara E, Marcato S, Cattini MG, Simioni P, Gallinaro L, Bertomoro A, Pagnan A |
| |
|
FVII Deficiency due to Homozygous FVII T324M Mutation
|
| Kemball-Cook G, Gomez K, Roscioli T, McVey JH |
| |
|
FVIIa Decreases Surgery-Induced IL-6 Response in Burn Patients Undergoing Excision and Skin Grafting
|
| Olsen EHN, Johansson PI, Eriksen K, Nielsen SL, Alsbjørn B, Rojkjaer R |
| |
|
FVIII-Dependent Propagation Phase Is of Minor Importance During Septic Peritonitis
|
| Brüggemann LW, Schoenmakers SHHF, Reitsma PH, Spek CA |
| |
|
FXI Deficiency in South Australia: Diversity of Causative Mutations within a Small Group of Affected Individuals
|
| Duncan EM, Fenech M, Casey G, Casey CR, Rodgers SE, Lee SH, Chunilal S, Lloyd JV |
| |
